Although the molecular mechanism of action of sortilin in breast cancer cells, and in particular its direct interacting partners, remain to be elucidated, our data suggest sortilin, as a new potential therapeutic target in breast cancer. The gene discussed is SORT1; the disease is breast carcinoma.